Insulet's (PODD) Sales And Margins Surpassed Expectations

Brown Capital Management's Mid Company Fund underperformed in Q2 2024, focusing on EGCs with strong growth. Highlighting Insulet Corporation's success, the fund sees potential in AI stocks for higher returns. Check top holdings for insights.